Boston Scientific's Acquisition of Apollo Endosurgery: Advancing Minimally Invasive Solutions for Patients

As Apollo Endosurgery officially becomes part of Boston Scientific, Astrid Monteau, vice president for Endoscopy, EMEA at Boston Scientific shares her thoughts on the value of this acquisition: what it brings to the company, our customers and the patients we serve around the world. 

“It’s not only the Apollo technology that we’re bringing into Boston Scientific that we’re excited about, but also the people, and it was great to meet many face-to-face recently at their European headquarters in Knaresborough, UK.” said Astrid.

Expanding our footprint in endoluminal surgery (ELS) and entering into the bariatrics field

Astrid says that the acquisition is an exciting step forward in the company’s ability to provide our customers and their patients with a more comprehensive and clinically differentiated suite of ELS and endobariatric technologies.

“ELS provides patients with treatment options that are less invasive than traditional surgery and innovation in this field is growing. Apollo’s focus on ELS procedures is very similar to ours, and the products they sell that address GI defects are complementary to our existing ELS portfolio. For instance, we did not have a suturing system like they do to close defects in the body. Additionally, the endobariatrics Apollo portfolio introduces Boston Scientific to a brand-new market.” 

Building an Endoscopy business that make procedures less invasive

Astrid emphasises that the focus of our Endoscopy business at Boston Scientific is centered around making procedures less invasive. “In the past, medical conditions required invasive surgery since endoscopic procedures were not yet available.  In recent years minimally invasive surgery became a reality thanks to accessories introduced through a flexible endoscope.  

“Our Endoscopy business has shifted its focus to ELS, which is a minimally invasive option for patients with gastrointestinal conditions or obesity. ELS can be a less invasive alternative to open and laparoscopic surgery for some patients with gastrointestinal tract diseases or obesity, resulting in a low rate of complications.”